Gravar-mail: Corrigendum to “Inhibition of Key Digestive Enzymes Related to Diabetes and Hyperlipidemia and Protection of Liver-Kidney Functions by Trigonelline in Diabetic Rats” [Sci Pharm. 2013; 81: 233–246]